Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)

F. Vernieri, C. Altamura, C. Aurilia, N. Brunelli, G. Egeo, L. Fofi, C.M. Costa, A. Fallacara, V. Favoni, G. Pierangeli, M. Aguggia, D. Bertuzzo, M. Albanese, P. Di Fiore, F. Frediani, S. Cevoli, P. Barbanti

Research output: Contribution to journalArticlepeer-review

Cite this